Dichloroacetate Reverses the Hypoxic Adaptation to Bevacizumab and Enhances its Antitumor Effects in Mouse Xenografts

Inhibition of vascular endothelial growth factor (VEGF) increases response rates to chemotherapy and progression-free survival in glioblastoma. However, resistance invariably occurs, prompting the urgent need for identification of synergizing agents. One possible strategy is to understand tumor adap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kumar, Krishnan, Wigfield, Simon, Gee, Harriet E., Devlin, Cecilia M., Singleton, Dean, Li, Ji-Liang, Buffa, Francesca, Huffman, Melanie, Sinn, Anthony L., Silver, Jayne, Turley, Helen, Leek, Russell, Harris, Adrian L, Ivan, Mircea
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3661713/
https://ncbi.nlm.nih.gov/pubmed/23361368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-013-0996-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados